Atrion (ATRI) Revenue & Revenue Breakdown

OverviewOwnership Financials Chart

Atrion Revenue Highlights

Latest Revenue (Q)

$48.77M

Main Segment (Y)

Fluid Delivery

Main Geography (Y)

United State

Atrion Revenue by Period

Atrion Revenue by Year

Date	Revenue	Change
2023-12-31	-	-100.00%
2022-12-31	$183.51M	11.21%
2021-12-31	$165.01M	11.80%
2020-12-31	$147.59M	-4.82%
2019-12-31	$155.07M	1.72%
2018-12-31	$152.45M	3.99%
2017-12-31	$146.59M	2.17%
2016-12-31	$143.49M	-1.54%
2015-12-31	$145.73M	3.53%
2014-12-31	$140.76M	6.64%
2013-12-31	$131.99M	10.86%
2012-12-31	$119.06M	1.15%
2011-12-31	$117.70M	8.41%
2010-12-31	$108.57M	7.88%
2009-12-31	$100.64M	4.95%
2008-12-31	$95.89M	8.31%
2007-12-31	$88.54M	9.28%
2006-12-31	$81.02M	12.39%
2005-12-31	$72.09M	9.09%
2004-12-31	$66.08M	5.22%
2003-12-31	$62.80M	5.49%
2002-12-31	$59.53M	3.35%
2001-12-31	$57.60M	11.97%
2000-12-31	$51.45M	3.10%
1999-12-31	$49.90M	14.98%
1998-12-31	$43.40M	43.23%
1997-12-31	$30.30M	-77.72%
1996-12-31	$136.00M	69.15%
1995-12-31	$80.40M	14.37%
1994-12-31	$70.30M	-40.92%
1993-12-31	$119.00M	-

Atrion generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Atrion Revenue by Quarter

Date	Revenue	Change
2024-06-30	$48.77M	3.04%
2024-03-31	$47.33M	8.60%
2023-12-31	$43.58M	3.99%
2023-09-30	$41.91M	-4.40%
2023-06-30	$43.84M	9.61%
2023-03-31	$39.99M	-6.68%
2022-12-31	$42.85M	-3.98%
2022-09-30	$44.63M	-8.70%
2022-06-30	$48.88M	3.70%
2022-03-31	$47.14M	16.99%
2021-12-31	$40.29M	-5.98%
2021-09-30	$42.85M	0.38%
2021-06-30	$42.69M	9.00%
2021-03-31	$39.17M	21.48%
2020-12-31	$32.24M	-4.56%
2020-09-30	$33.78M	-11.02%
2020-06-30	$37.97M	-12.91%
2020-03-31	$43.59M	26.48%
2019-12-31	$34.47M	-11.36%
2019-09-30	$38.88M	-3.04%
2019-06-30	$40.10M	-3.63%
2019-03-31	$41.61M	19.15%
2018-12-31	$34.93M	-11.07%
2018-09-30	$39.27M	1.10%
2018-06-30	$38.85M	-1.41%
2018-03-31	$39.40M	15.80%
2017-12-31	$34.02M	-10.23%
2017-09-30	$37.90M	4.81%
2017-06-30	$36.16M	-6.08%
2017-03-31	$38.50M	15.65%
2016-12-31	$33.29M	-12.00%
2016-09-30	$37.84M	4.68%
2016-06-30	$36.14M	-0.20%
2016-03-31	$36.22M	11.87%
2015-12-31	$32.37M	-13.40%
2015-09-30	$37.38M	-0.73%
2015-06-30	$37.66M	-1.75%
2015-03-31	$38.32M	17.22%
2014-12-31	$32.69M	-10.74%
2014-09-30	$36.63M	4.57%
2014-06-30	$35.02M	-3.83%
2014-03-31	$36.42M	14.34%
2013-12-31	$31.85M	-6.44%
2013-09-30	$34.04M	4.41%
2013-06-30	$32.60M	11.51%
2013-03-31	$29.24M	2.60%
2012-12-31	$28.50M	-6.99%
2012-09-30	$30.64M	-0.17%
2012-06-30	$30.69M	4.96%
2012-03-31	$29.24M	14.58%
2011-12-31	$25.52M	-16.21%
2011-09-30	$30.46M	-2.19%
2011-06-30	$31.14M	1.80%
2011-03-31	$30.59M	14.87%
2010-12-31	$26.63M	-1.94%
2010-09-30	$27.16M	-2.60%
2010-06-30	$27.88M	3.64%
2010-03-31	$26.90M	10.24%
2009-12-31	$24.40M	-3.13%
2009-09-30	$25.19M	-3.11%
2009-06-30	$26.00M	3.81%
2009-03-31	$25.05M	6.18%
2008-12-31	$23.59M	0.55%
2008-09-30	$23.46M	-3.22%
2008-06-30	$24.24M	-1.46%
2008-03-31	$24.60M	17.22%
2007-12-31	$20.99M	-

Atrion generated $48.77M in revenue during Q2 2024, up 3.04% compared to the previous quarter, and up 121.95% compared to the same period a year ago.

Atrion Revenue Breakdown

Atrion Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 19	Dec 18
Fluid Delivery	$72.12M	$70.61M
Cardiovascular	$54.80M	$50.90M
Ophthalmology	$7.12M	-
Other	$21.03M	$20.46M
Opthalmology	-	$10.47M

Atrion's latest annual revenue breakdown by segment (product or service), as of Dec 19: Fluid Delivery (46.51%), Cardiovascular (35.34%), Other (13.56%), and Ophthalmology (4.59%).

Quarterly Revenue by Product

Product/Service	Sep 20	Jun 20	Mar 20	Dec 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
Fluid Delivery	$16.51M	$21.76M	$22.35M	$17.78M	$18.16M	$16.57M	$17.11M	$18.13M	$18.80M
Cardiovascular	$11.30M	$10.84M	$14.82M	$10.23M	$15.42M	$11.40M	$13.29M	$13.00M	$13.21M
Ophthalmology	$1.17M	$936.00K	$863.00K	$1.47M	$2.28M	$2.77M	$2.85M	$2.79M	-
Other	$4.80M	$4.43M	$5.56M	$4.98M	-	-	-	-	-
Other Products	-	-	-	-	$5.75M	$6.11M	$4.86M	$4.61M	-

Atrion's latest quarterly revenue breakdown by segment (product or service), as of Sep 20: Fluid Delivery (48.87%), Cardiovascular (33.44%), Other (14.22%), and Ophthalmology (3.47%).

Atrion Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 19	Dec 18
All Other Regions	$43.45M	-	-
United State	$109.74M	-	-
European Union	$30.31M	-	-
Germany	-	$8.00M	$8.90M
United States	-	$98.50M	$95.76M
Other Countries	-	$48.57M	$47.79M

Atrion's latest annual revenue breakdown by geography, as of Dec 22: United State (59.80%), All Other Regions (23.68%), and European Union (16.52%).

Quarterly Revenue by Country

Country	Sep 22	Sep 20	Jun 20	Mar 20	Dec 19	Mar 19	Dec 18	Sep 18	Jun 18	Mar 18
European Union	$6.37M	-	-	-	-	-	-	-	-	-
All other regions	$10.48M	-	-	-	-	-	-	-	-	-
United States	$27.78M	$21.86M	-	-	-	-	-	-	-	-
Ophthalmology	-	$1.17M	-	-	-	-	-	-	-	-
Other	-	$4.80M	-	-	-	-	-	-	-	-
Other Countries Less Than 5% Of Revenues	-	$11.38M	$15.52M	$14.16M	-	-	-	-	-	-
Cardiovascular	-	$11.30M	-	-	-	-	-	-	-	-
Fluid Delivery	-	$16.51M	-	-	-	-	-	-	-	-
UNITED STATES	-	-	-	$26.19M	-	-	-	-	-	-
GERMANY	-	-	-	$3.24M	-	-	-	-	-	-
Other Countries	-	-	-	-	$11.04M	$12.46M	$10.33M	$13.62M	$11.72M	$12.12M
Germany	-	-	-	-	$1.57M	$2.16M	$1.68M	$2.29M	$2.67M	-
U S	-	-	-	-	-	$26.99M	$23.98M	$24.83M	$24.61M	-

Atrion's latest quarterly revenue breakdown by geography, as of Sep 22: United States (62.24%), All other regions (23.48%), and European Union (14.27%).

Atrion Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
COO	Cooper Companies	$3.59B	$1.00B
ATR	AptarGroup	$3.49B	$909.29M
NVST	Envista	$2.57B	$884.70M
ICUI	ICU Medical	$2.26B	$589.13M
HAE	Haemonetics	$1.31B	$336.17M
MMSI	Merit Medical Systems	$1.26B	$339.85M
ATRC	AtriCure	$399.25M	$115.91M
ANGO	AngioDynamics	$303.91M	$67.49M
NSTG	NanoString	$127.26M	$48.09M
AKYA	Akoya Biosciences	$96.63M	$18.81M
KRMD	KORU Medical Systems	$28.52M	$8.18M
ATRI	Atrion	-	$48.77M

ATRI Revenue FAQ

What is Atrion’s yearly revenue?

Atrion's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $183.51M, representing an increase of 11.21% compared to 2021. ATRI's yearly revenue for 2021 was $165.01M, representing an increase of 11.80% compared to 2020.

What is Atrion’s quarterly revenue?

Atrion's quarterly revenue for Q2 2024 was $48.77M, a 3.04% increase from the previous quarter (Q1 2024), and a 11.26% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $47.33M, a 8.60% increase from the previous quarter (Q4 2023), and a 18.36% increase year-over-year (Q1 2023). ATRI's quarterly revenue for Q4 2023 was $43.58M, a 3.99% increase from the previous quarter (Q3 2023), and a 1.70% increase year-over-year (Q4 2022).

What is Atrion’s revenue growth rate?

Atrion's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.

What are Atrion’s revenue streams?

Atrion's revenue streams in c 19 are Fluid Delivery, Cardiovascular, Ophthalmology, and Other. Fluid Delivery generated $72.12M in revenue, accounting 46.51% of the company's total revenue, up 2.14% year-over-year. Cardiovascular generated $54.8M in revenue, accounting 35.34% of the company's total revenue, up 7.65% year-over-year. Ophthalmology generated $7.12M in revenue, accounting 4.59% of the company's total revenue Other generated $21.03M in revenue, accounting 13.56% of the company's total revenue, up 2.74% year-over-year.

What is Atrion’s main source of revenue?

For the fiscal year ending Dec 19, the largest source of revenue of Atrion was Fluid Delivery. This segment made a revenue of $72.12M, representing 46.51% of the company's total revenue.